TIKOMED AB
556622-8960ActiveDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
Oversigt
- 1–4
- Medarbejdere
- 10–20mio SEK
- Omsætning
- 2002
- Grundlagt
Nøglebeslutningstagere
Erika Egrelius
Head of Quality Assurance
Merit Cudkowicz
Scientific Advisory Board Member
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
+17 flere kontakter i Funnelfeedr
Beskrivelse
TikoMed AB is a privately owned Swedish company established in 2002, focused on groundbreaking scientific innovation in drug development. The core of their work revolves around developing ILB®, a novel molecule demonstrating unique properties in stimulating the body’s natural repair mechanisms. This...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556622896001
Beslutningstagere
21 kontakter i FunnelfeedrErika Egrelius
Head of Quality Assurance
Merit Cudkowicz
Scientific Advisory Board Member
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
Jeremy Shefner
Scientific Advisory Board Member
Christian Treschow
Chairman
Estefanía Coral
Head of Communications
Juan Vergez
Board Member
Björn Pilström
Chief Executive Officer, Chief Medical Officer
Martin Bruce
Board Member
Anita Westin Tocaj
Head of Regulatory Affairs
Annika Kollén
Board Member
Tobhias Brandell
Board Member
Caroline Ingre
Scientific Advisory Board Member
Henrik Otendal
Chief Financial Officer, Human Resource Manager
Staffan Dahlgren
Head of Drug Safety
Adriano Chiò
Scientific Advisory Board Member
Christina Herder
Chair of the Board
Antonio Bermejo Gomez
Head of CMC
Johan Olsson
Head of Accounting
Anders Svensson
Board Member
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrLobSor Pharmaceuticals Aktiebolag
3 medarbejdereDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Integrative Research Laboratories Sweden AB
20–49 medarbejdereDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Grespo AB
0 medarbejdereYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Lipigon Pharmaceuticals AB
5–9 medarbejdereClinical-stage company developing novel drugs for lipid disorders.
AQILION AB
5–9 medarbejdereDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Udforsk mere
Spørgsmål om TIKOMED AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo